Kraj: Izrael
Język: angielski
Źródło: Ministry of Health
CEFTIOFUR HYDROCHLORIDE
ZOETIS ISRAEL HOLDING B.V., ISRAEL
SUSPENSION FOR INJECTION
CEFTIOFUR HYDROCHLORIDE 50 MG / 1 ML
I.M, S.C
Required
ZOETIS BELGIUM S.A.
Infections associated with bacteria sensitive to ceftiofur: * In pigs : For the treatment of bacterial respiratory disease associated with Pasteurella multocida Actinobacillus pleuropneumoniae and Streptococcus suis. *In cattle : For the treatment of bacterial respiratory disease associated with Mannheimia haemolytica (former pasteurella haemolytica) Pasteurella multocida and Histophilus somni (fomer Haemophilus somnus). For the treatment of acute interdigital necrobacillosis ( panaritium foot rot) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus (Porphyromonas asaccharolytica). For treatment of the bacterial coponent of acute post-partum (puerperal) metritis within 10 days after calving associated with Escherichia coli Arcanobacterium pyogenes and Fusobacteriu necrophorum sensitive to ceftiofur where treatment with another antimicrobial agent has failed.
2022-01-31
CONSUMER PACKAGE INSERT FOR A VETERINARY PREPARATION The medicine is dispensed with a veterinarian’s prescription only For animal use only 1. NAME, FORM AND STRENGTH OF THE VETERINARY MEDICINE Excenel RTU Fluid Veterinary suspension for intramuscular and subcutaneous injection 2. ACTIVE INGREDIENT Ceftiofur (as hydrochloride) 50 mg/ ml The list of inactive ingredients is in section 13. 3. WHAT IS THE MEDICINE INTENDED FOR? For treatment of infections associated with bacteria sensitive to ceftiofur. In pigs For the treatment of bacterial respiratory disease associated with: _Pasteurella multocida_, _ Actinobacillus pleuropneumoniae_ and _Streptococcus suis_. In cattle For the treatment of bacterial respiratory disease associated with: _Mannheimia haemolytica_ (former _Pasteurella haemolytica_), _Pasteurella _ _multocida_ and _Histophilus somni_ (former _Haemophilus somnus_). For the treatment of acute interdigital necrobacillosis (Panaritium Foot Rot) associated with: _Fusobacterium necrophorum_ and _Bacteroides _ _melaninogenicus_ (_Porphyromonas asaccharolytica_). For treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving associated with: _Arcanobacterium pyogenes, Escherichia coli _ and _ Fusobacteriu _ _necrophorum_ sensitive to ceftiofur where treatment with another antimicrobial agent has failed. Therapeutic group: Antibacterials for systemic use. Third-generation cephalosporins. 4. CONTRAINDICATIONS Do not use if the animal has a known hypersensitivity to ceftiofur and other beta-lactam antibiotics. Do not inject intravenously. Do not use in case of resistance to cephalosporins or to other beta- lactam antibiotics. Do not use in poultry (including egg laying poultry), to prevent spread of variants resistant to the preparation to humans. 5. SIDE EFFECTS Hypersensitivity reactions unrelated to the dosage can occur. Allergic reactions (e.g., skin reactions or anaphylaxis) have very rarely been reported (fewer than one in 10,000 animals, including isolated Przeczytaj cały dokument